Carotuximab

Tax included
Carotuximab (TRC105) is a IgG1 monoclonal antibody that blocks endoglin (CD105) and its downstream Smad signaling pathway. Carotuximab has immunomodulatory and antineoplastic actions.
MedChemExpress 
HY-P99494

Data sheet

Size
Multiple sizes
Reactivity
TGF-beta/Smad
CAS
1268714-50-6